View Item 

Show simple item record

American Thoracic Society 2019 Pediatric Core Curriculum
dc.contributor.authorMoore, Paul E.
dc.contributor.authorBoyer, Debra
dc.contributor.authorPerkins, Ryan
dc.contributor.authorKatz, Eliot S.
dc.contributor.authorCastro‐codesal, Maria L.
dc.contributor.authorMacLean, Joanna E.
dc.contributor.authorAkil, Nour
dc.contributor.authorEsther, Charles R.
dc.contributor.authorKaslow, Jacob
dc.contributor.authorLewis, Toby C.
dc.contributor.authorKrone, Katie A.
dc.contributor.authorQuizon, Annabelle
dc.contributor.authorSimpson, Ryne
dc.contributor.authorBenscoter, Dan
dc.contributor.authorSpielberg, David R.
dc.contributor.authorMelicoff, Ernestina
dc.contributor.authorKuklinski, Cadence A.
dc.contributor.authorBlatter, Joshua A.
dc.contributor.authorDy, Jamie
dc.contributor.authorRettig, Jordan S.
dc.contributor.authorHorani, Amjad
dc.contributor.authorGross, Jane
dc.date.accessioned2020-01-13T15:04:14Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-01-13T15:04:14Z
dc.date.issued2019-12
dc.identifier.citationMoore, Paul E.; Boyer, Debra; Perkins, Ryan; Katz, Eliot S.; Castro‐codesal, Maria L. ; MacLean, Joanna E.; Akil, Nour; Esther, Charles R.; Kaslow, Jacob; Lewis, Toby C.; Krone, Katie A.; Quizon, Annabelle; Simpson, Ryne; Benscoter, Dan; Spielberg, David R.; Melicoff, Ernestina; Kuklinski, Cadence A.; Blatter, Joshua A.; Dy, Jamie; Rettig, Jordan S.; Horani, Amjad; Gross, Jane (2019). "American Thoracic Society 2019 Pediatric Core Curriculum." Pediatric Pulmonology 54(12): 1880-1894.
dc.identifier.issn8755-6863
dc.identifier.issn1099-0496
dc.identifier.urihttps://hdl.handle.net/2027.42/152541
dc.description.abstractThe American Thoracic Society Pediatric Core Curriculum updates clinicians annually in pediatric pulmonary disease in a 3 to 4 year recurring cycle of topics. The 2019 course was presented in May during the Annual International Conference. An American Board of Pediatrics Maintenance of Certification module and a continuing medical education exercise covering the contents of the Core Curriculum can be accessed online at www.thoracic.org.
dc.publisherWiley Periodicals, Inc.
dc.publisherAmerican Academy of Pediatrics
dc.subject.otherpulmonary vascular malformations
dc.subject.otherlymphatic disorders
dc.subject.otherobstructive sleep apnea
dc.subject.otherpediatric sleep
dc.subject.otherpneumonia
dc.subject.othertransplant complications
dc.titleAmerican Thoracic Society 2019 Pediatric Core Curriculum
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152541/1/ppul24482_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152541/2/ppul24482.pdf
dc.identifier.doi10.1002/ppul.24482
dc.identifier.sourcePediatric Pulmonology
dc.identifier.citedreferenceAdams DM, Trenor CC 3rd, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016; 137 ( 2 ): e20153257.
dc.identifier.citedreferenceInde Y, Yamagishi E, Kawabata I, Sekiguchi A, Nakai A, Takeshita T. Morphological changes observed via fetal ultrasound in prenatally diagnosed and isolated congenital lymphangiomas: three case reports. J Med Ultrason. 2013; 40 ( 3 ): 265 â 269.
dc.identifier.citedreferenceKoelblinger C, Herold C, Nemec S, et al. Fetal magnetic resonance imaging of lymphangiomas. J Perinat Med. 2013; 41 ( 4 ): 437 â 443.
dc.identifier.citedreferenceMerrow AC, Gupta A, Patel MN, Adams DM. 2014 revised classification of vascular lesions from the international society for the study of vascular anomalies: radiologicâ pathologic update. Radiographics. 2016; 36 ( 5 ): 1494 â 1516.
dc.identifier.citedreferenceSteinklein JM, Shatzkes DR. Imaging of vascular lesions of the head and neck. Otolaryngol Clin North Am. 2018; 51 ( 1 ): 55 â 76.
dc.identifier.citedreferenceWaner M, O TM. Multidisciplinary approach to the management of lymphatic malformations of the head and neck. Otolaryngol Clin North Am. 2018; 51 ( 1 ): 159 â 172.
dc.identifier.citedreferenceGreene AK, Perlyn CA, Alomari AI. Management of lymphatic malformations. Clin Plast Surg. 2011; 38 ( 1 ): 75 â 82.
dc.identifier.citedreferenceSmith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJH. Efficacy and safety of okâ 432 immunotherapy of lymphatic malformations. Laryngoscope. 2009; 119 ( 1 ): 107 â 115.
dc.identifier.citedreferenceDanial C, Tichy AL, Tariq U, et al. An openâ label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol. 2014; 70 ( 6 ): 1050 â 1057.
dc.identifier.citedreferenceSwetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL. Sildenafil for severe lymphatic malformations. N Engl J Med. 2012; 366 ( 4 ): 384 â 386.
dc.identifier.citedreferenceTriana P, Dore M, Cerezo VN, et al. Sirolimus in the treatment of vascular anomalies. Eur J Pediatr Surg. 2017; 27 ( 1 ): 86 â 90.
dc.identifier.citedreferenceHammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011; 57 ( 6 ): 1018 â 1024.
dc.identifier.citedreferenceWassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015; 136 ( 1 ): e203 â e214.
dc.identifier.citedreferenceISSVA Classification of Vascular Anomalies ©2018 International Society for the Study of Vascular Anomalies Available at "issva.org/classification" Accessed [June 13, 2019]
dc.identifier.citedreferenceMerrow AC, Gupta A, Patel MN, Adams DM. 2014 Revised classification of vascular lesions from the International Society for the Study of Vascular Anomalies: radiologicâ pathologic update. Radiographics. 2016; 36 ( 5 ): 1494 â 1516.
dc.identifier.citedreferenceGreene AK, Goss JA. Vascular anomalies: from a clinicohistologic to a genetic framework. Plast Reconstr Surg. 2018; 141 ( 5 ): 709e â 717e.
dc.identifier.citedreferenceAlâ Saleh S, Dragulescu A, Manson D, et al. Utility of contrast echocardiography for pulmonary arteriovenous malformation screening in pediatric hereditary hemorrhagic telangiectasia. J Pediatr. 2012; 160 ( 6 ): 1039 â 1043.e1.
dc.identifier.citedreferenceFaughnan ME, Thabet A, Meiâ Zahav M, et al. Pulmonary arteriovenous malformations in children: outcomes of transcatheter embolotherapy. J Pediatr. 2004; 145 ( 6 ): 826 â 831.
dc.identifier.citedreferenceMowers KL, Sekarski L, White AJ, Grady RM. Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study. Pulm Circ. 2018; 8 ( 3 ): 2045894018786696.
dc.identifier.citedreferenceFaughnan ME, Palda VA, Garciaâ Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011; 48 ( 2 ): 73 â 87.
dc.identifier.citedreferenceNakano TA, Zeinati C. Venous thromboembolism in pediatric vascular anomalies. Front Pediatr. 2017; 5: 158.
dc.identifier.citedreferenceDarrow DH. Management of infantile hemangiomas of the airway. Otolaryngol Clin North Am. 2018; 51 ( 1 ): 133 â 146.
dc.identifier.citedreferenceShah SD, Baselga E, McCuaig C, et al. Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics. 2016; 137 ( 4 ): e20151754.
dc.identifier.citedreferenceMichelson PH, Goyal R, Kurland G. Pulmonary complications of haematopoietic cell transplantation in children. Paediatr Respir Rev. 2007; 8: 46 â 61.
dc.identifier.citedreferenceKaya Z, Weiner DJ, Yilmaz D, Rowan J, Goyal RK. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Biol Blood Marrow Transplant. 2009; 15: 817 â 826.
dc.identifier.citedreferenceSrinivasan A, Srinivasan S, Sunthankar S, et al. Preâ hematopoietic stem cell transplant lung function and pulmonary complications in children. Ann Am Thorac Soc. 2014; 11 ( 10 ): 1576 â 1585.
dc.identifier.citedreferenceKasow KA, Krueger J, Srivastava DK, et al. Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience. Biol Blood Marrow Transplant. 2009; 15: 490 â 495.
dc.identifier.citedreferenceParimon T, Madtes DK, Au DH, Clark JG, Chien JW. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med. 2005; 172: 384 â 390.
dc.identifier.citedreferenceAu BKC, Gooley TA, Armand P, et al. Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant. 2015; 21: 848 â 854.
dc.identifier.citedreferenceLucena CM, Torres A, Rovira M, et al. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant. 2014; 49: 1293 â 1299.
dc.identifier.citedreferenceHayesâ Jordan A, Benaim E, Richardson S, et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg. 2002; 37 ( 3 ): 446 â 452.
dc.identifier.citedreferenceJagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graftâ versusâ Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015; 21 ( 3 ): 389 â 401.e1.
dc.identifier.citedreferenceBergeron A, Cheng GS. Bronchiolitis obliterans syndrome and other late pulmonary complications after allogeneic hematopoietic stem cell transplantation. Clin Chest Med. 2017; 38 ( 4 ): 607 â 621.
dc.identifier.citedreferenceNational Asthma Education and Prevention Program. Expert Panel Report 3 (EPRâ 3): guidelines for the diagnosis and management of asthmaâ summary report 2007. J Allergy Clin Immunol. 2007; 120: S94 â S138.
dc.identifier.citedreferenceChiswell C, Akram Y. Impact of environmental tobacco smoke exposure on anaesthetic and surgical outcomes in children: a systematic review and metaâ analysis. Arch Dis Child. 2017; 102: 123 â 130.
dc.identifier.citedreferenceJha SR, Hannu MK, Chang S, et al. The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation. Transplantation. 2016; 100: 429 â 436.
dc.identifier.citedreferenceRavenscraft SA, Gross CR, Kubo SH, et al. Pulmonary function after successful heart transplantation. Chest. 1993; 103: 54 â 58.
dc.identifier.citedreferenceUlrik CS, Carlsen J, Arendrup H, Aldershvile J. Pulmonary function in chronic heart failure. Changes after heart transplantation. Scand Cardiovasc J. 1999; 33: 131 â 136.
dc.identifier.citedreferenceQaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006; 144: 575 â 580.
dc.identifier.citedreferenceKotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2004; 170: 22 â 48.
dc.identifier.citedreferenceGreen M. Introduction: infections in solid organ transplantation. Am J Transplant. 2013; 13 ( Suppl 4 ): 3 â 8.
dc.identifier.citedreferenceLee SH, Huh KH, Joo DJ, et al. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. Sci Rep. 2017; 7: 1571.
dc.identifier.citedreferenceHorne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013; 57: 1473 â 1482.
dc.identifier.citedreferenceChatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J. 2003; 21: 502 â 508.
dc.identifier.citedreferenceIkeda K, Kawakami K, Onimaru H, et al. The respiratory control mechanisms in the brainstem and spinal cord: integrative views of the neuroanatomy and neurophysiology. J Physiol Sci. 2016; 67: 45 â 62.
dc.identifier.citedreferenceSmith CA, Forster HV, Blain GM, Dempsey JA. An interdependent model of central/peripheral chemoreception: Evidence and implications for ventilatory control. Respir Physiol Neurobiol. 2010; 173: 288 â 297.
dc.identifier.citedreferenceDempsey JA, Smith CA. Pathophysiology of human ventilatory control. Eur Respir J. 2014; 44: 495 â 512.
dc.identifier.citedreferenceDempsey JA, Morgan BJ. Humans in hypoxia: a conspiracy of maladaptation?! Physiology. 2015; 30: 304 â 316.
dc.identifier.citedreferenceEckert DJ. Phenotypic approaches to obstructive sleep apnoea â new pathways for targeted therapy. Sleep Med Rev. 2018; 37: 45 â 59.
dc.identifier.citedreferenceAmatoury J, Azarbarzin A, Younes M, Jordan AS, Wellman A, Eckert DJ. Arousal intensity is a distinct pathophysiological trait in obstructive sleep apnea. Sleep. 2016; 39: 2091 â 2100.
dc.identifier.citedreferenceKatz ES, D’Ambrosio CM. Pathophysiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5: 253 â 262.
dc.identifier.citedreferenceForster HV, Haouzi P, Dempsey JA. Control of breathing during exercise. Compr Physiol. 2012; 2: 743 â 777.
dc.identifier.citedreferenceAinslie PN, Lucas SJE, Burgess KR. Breathing and sleep at high altitude. Respir Physiol Neurobiol. 2013; 188: 233 â 256.
dc.identifier.citedreferenceRosen CL, Wang R, Taylor HG, et al. Utility of symptoms to predict treatment outcomes in obstructive sleep apnea syndrome. Pediatrics. 2015; 135 ( 3 ): e662 â e671.
dc.identifier.citedreferencePapaioannou G, Kambas I, Tsaoussoglou M, Panaghiotopoulouâ Gartagani P, Chrousos G, Kaditis AG. Ageâ dependent changes in the size of adenotonsillar tissue in childhood: implications for sleepâ disordered breathing. J Pediatr. 2013; 162 ( 2 ): 269 â 274.
dc.identifier.citedreferenceMarcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013; 368 ( 25 ): 2366 â 2376.
dc.identifier.citedreferenceKirk V, Baughn J, D’Andrea L, et al. American academy of sleep medicine position paper for the use of a home sleep apnea test for the diagnosis of osa in children. J Clin Sleep Med. 2017; 13 ( 10 ): 1199 â 1203.
dc.identifier.citedreferenceNixon GM, Davey MJ, Weichard AJ, Horne RSC. Oximetry for suspected obstructive sleep apneaâ does removal of awake data affect the result? Pediatr Pulmonol. 2016; 51 ( 12 ): 1409 â 1413.
dc.identifier.citedreferenceHornero R, Kheirandishâ Gozal L, Gutiérrezâ Tobal GC, et al. Nocturnal oximetryâ based evaluation of habitually snoring children. Am J Respir Crit Care Med. 2017; 196 ( 12 ): 1591 â 1598.
dc.identifier.citedreferenceManickam PV, Shott SR, Boss EF, et al. Systematic review of site of obstruction identification and nonâ cpap treatment options for children with persistent pediatric obstructive sleep apnea. Laryngoscope. 2016; 126 ( 2 ): 491 â 500.
dc.identifier.citedreferenceCollu MA, Esteller E, Lipari F, et al. A caseâ control study of drugâ induced sleep endoscopy (dise) in pediatric population: a proposal for indications. Int J Pediatr Otorhinolaryngol. 2018; 108: 113 â 119.
dc.identifier.citedreferenceFleck RJ, Shott SR, Mahmoud M, Ishman SL, Amin RS, Donnelly LF. Magnetic resonance imaging of obstructive sleep apnea in children. Pediatr Radiol. 2018; 48 ( 9 ): 1223 â 1233.
dc.identifier.citedreferenceVenekamp RP, Hearne BJ, Chandrasekharan D, Blackshaw H, Lim J, Schilder AG. Tonsillectomy or adenotonsillectomy versus nonâ surgical management for obstructive sleepâ disordered breathing in children. Cochrane Database Syst Rev. 2015; 10: CD011165.
dc.identifier.citedreferenceWhitla L, Lennon P. Nonâ surgical management of obstructive sleep apnoea: A review. Paediatr Int Child Health. 2017; 37 ( 1 ): 1 â 5.
dc.identifier.citedreferenceSakarya EU, Bayar Muluk N, Sakalar EG, et al. Use of intranasal corticosteroids in adenotonsillar hypertrophy. J Laryngol Otol. 2017; 131 ( 5 ): 384 â 390.
dc.identifier.citedreferenceYang DZ, Liang J, Zhang F, Yao HB, Shu Y. Clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of OSAS children. Medicine. 2017; 96 ( 19 ): e6628.
dc.identifier.citedreferenceCarvalho FR, Lentiniâ Oliveira DA, Prado LB, Prado GF, Carvalho LB. Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children. Cochrane Database Syst Rev. 2016; 10: CD005520.
dc.identifier.citedreferenceFletcher MA, Schmitt HJ, Syrochkina M, Sylvester G. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis. 2014; 33: 879 â 910.
dc.identifier.citedreferenceBradley JS, Byington CL, Shah SS, et al. The management of communityâ acquired pneumonia in infants and children older than 3 months of age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011; 53: e25 â e76.
dc.identifier.citedreferenceTracy MC, Mathew R. Complicated pneumonia: current concepts and state of the art. Curr Opin Pediatr. 2018; 30: 384 â 392.
dc.identifier.citedreferenceBaer G, Baumann P, Buettcher M, et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS One. 2013; 8: e68419.
dc.identifier.citedreferenceMyers AL, Hall M, Williams DJ, et al. Prevalence of bacteremia in hospitalized pediatric patients with communityâ acquired pneumonia. Pediatr Infect Dis J. 2013; 32: 736 â 740.
dc.identifier.citedreferenceBalfourâ Lynn IM, Paediatric Pleural Diseases Subcommittee of the BTSSoCC. BTS guidelines for the management of pleural infection in children. Thorax. 2005; 60 ( Suppl 1 ): i1 â i21.
dc.identifier.citedreferenceWiese AD, Griffin MR, Zhu Y, Mitchel EF Jr., Grijalva CG. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine. 2016; 34: 6243 â 6249.
dc.identifier.citedreferenceShah SS, Srivastava R, Wu S, et al. Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia. Pediatrics. 2016; 138: e20161692.
dc.identifier.citedreferenceShah SS, Ten Have TR, Metlay JP. Costs of treating children with complicated pneumonia: a comparison of primary videoâ assisted thoracoscopic surgery and chest tube placement. Pediatr Pulmonol. 2010; 45: 71 â 77.
dc.identifier.citedreferenceThomson AH, Hull J, Kumar MR, Wallis C, Balfour Lynn IM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002; 57: 343 â 347.
dc.identifier.citedreferenceCharlton CL, Babady E, Ginocchio CC, et al. Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections. Clin Microbiol Rev. 2018; 32: e00042 â 18.
dc.identifier.citedreferenceMahony JB. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev. 2008; 21: 716 â 747.
dc.identifier.citedreferenceGill PJ, Richardson SE, Ostrow O, Friedman JN. Testing for respiratory viruses in children: to swab or not to swab. JAMA Pediatr. 2017; 171: 798 â 804.
dc.identifier.citedreferenceDas S, Dunbar S, Tang YW. Laboratory diagnosis of respiratory tract infections in children â the state of the art. Front Microbiol. 2018; 9: 2478.
dc.identifier.citedreferenceFlannery B, Reynolds SB, Blanton L, et al. Influenza vaccine effectiveness against pediatric deaths: 2010â 2014. Pediatrics. 2017; 139: e20164244.
dc.identifier.citedreferenceChung JR, Flannery B, Ambrose CS, et al. Live attenuated and inactivated influenza vaccine effectiveness. Pediatrics. 2019; 143: e20182094.
dc.identifier.citedreferenceAmerican Academy of Pediatrics Committee on Infectious D. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014; 134: e620 â e638.
dc.identifier.citedreferenceAmerican Academy of Pediatrics. Respiratory syncytial virus. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018.
dc.identifier.citedreferenceMalosh RE, Martin ET, Heikkinen T, Brooks WA, Whitley RJ, Monto AS. Efficacy and safety of oseltamivir in children: systematic review and individual patient data metaâ analysis of randomized controlled trials. Clin Infect Dis. 2018; 66: 1492 â 1500.
dc.identifier.citedreferenceSimões EAF, Bont L, Manzoni P, et al. Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children. Infect Dis Ther. 2018; 7: 87 â 120.
dc.identifier.citedreferencePerkins JA. New frontiers in our understanding of lymphatic malformations of the head and neck: natural history and basic research. Otolaryngol Clin North Am. 2018; 51 ( 1 ): 147 â 158.
dc.identifier.citedreferenceBrouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest. 2014; 124 ( 3 ): 898 â 904.
dc.identifier.citedreferenceElluru RG, Azizkhan RG. Cervicofacial vascular anomalies. Ii. Vascular malformations. Semin Pediatr Surg. 2006; 15 ( 2 ): 133 â 139.
dc.identifier.citedreferenceHochman M, Adams DM, Reeves TD. Current knowledge and management of vascular anomalies, ii: Malformations. Arch Facial Plast Surg. 2011; 13 ( 6 ): 425 â 433.
dc.identifier.citedreferencede Serres LM, Sie KCY, Richardson MA. Lymphatic malformations of the head and neck: a proposal for staging. Arch Otolaryngol Head Neck Surg. 1995; 121 ( 5 ): 577 â 582.
dc.identifier.citedreferenceElluru RG, Balakrishnan K, Padua HM. Lymphatic malformations: diagnosis and management. Semin Pediatr Surg. 2014; 23 ( 4 ): 178 â 185.
dc.identifier.citedreferenceBrown LR, Reiman HM, Rosenow EC 3rd, Gloviczki PM, Divertie MB. Intrathoracic lymphangioma. Mayo Clin Proc. 1986; 61 ( 11 ): 882 â 892.
dc.identifier.citedreferenceDrut R, Mosca HH. Intrapulmonary cystic lymphangioma. Pediatr Pulmonol. 1996; 22 ( 3 ): 204 â 206.
dc.identifier.citedreferenceFaul JL, Berry GJ, Colby TV, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med. 2000; 161 ( 3 Pt 1 ): 1037 â 1046.
dc.identifier.citedreferenceAviv RI, McHugh K, Hunt J. Angiomatosis of bone and soft tissue: a spectrum of disease from diffuse lymphangiomatosis to vanishing bone disease in young patients. Clin Radiol. 2001; 56 ( 3 ): 184 â 190.
dc.identifier.citedreferenceNikolaou VS, Chytas D, Korres D, Efstathopoulos N. Vanishing bone disease (gorhamâ stout syndrome): a review of a rare entity. World J Orthop. 2014; 5 ( 5 ): 694 â 698.
dc.identifier.citedreferenceLarkin SC, Wentworth AB, Lehman JS, Tollefson MM. A case of extensive acquired progressive lymphangioma. Pediatr Dermatol. 2018; 35 ( 4 ): 486 â 489.
dc.identifier.citedreferenceConnell F, Brice G, Mortimer P. Phenotypic characterization of primary lymphedema. Ann N Y Acad Sci. 2008; 1131: 140 â 146.
dc.identifier.citedreferenceToroâ Solá MA. Distichiasisâ lymphedema syndrome and the turner phenotype. Bol Asoc Med P R. 1991; 83 ( 12 ): 543 â 544.
dc.identifier.citedreferenceWassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015; 136 ( 1 ): e203 â e214.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ppul24482_am.pdf
Size:
296.2KB
Format:
PDF
View/Open
Name:
ppul24482.pdf
Size:
1.007MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.